逆转录转座子LINE-1与肿瘤的发生和发展

doi:10.16288/j.yczz.15-470

[an error occurred while processing this directive]

HEREDITAS(Beijing) ›› 2016, Vol. 38 ›› Issue (2): 93-102.doi: 10.16288/j.yczz.15-470

• Reviews • Next Articles

The connection between LINE-1 retrotransposition and human tumorigenesis

Qian Liu¹, Jinhui Wang², Xiaoyu Li¹, Shan Cen¹

1. Department of Immunology, Institute of Medicinal Biotechnology, Chinese academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;
2. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Received:2015-11-16 Revised:2015-12-02 Online:2016-02-20 Published:2016-01-05

Abstract

Abstract: LINE-1 is the only currently known active autonomous transposon in humans with an estimated 500 000 copies representing 17% of the human genome. LINE-1 propagates itself through a process called retrotransposition, which includes transcription and reverstranscription, to produce new DNA copies. The new produced DNA copies can integrate into new genomic loci. The insertion of LINE-1 is able to cause genetic instability by affecting the expression or regulation of the nearby genes, thus causing dozens of genetic diseases or tumors. In this review, we summarize the recent research progress on the connection between LINE-1 retrotransposition and human tumorigenesis, which might shed light on the biology mechanisms and treatment of the tumorigenesis.

Key words: transposition, retrotransposon, genome, LINE-1, tumor, genetic instability, reverstranscriptease

Qian Liu, Jinhui Wang, Xiaoyu Li, Shan Cen. The connection between LINE-1 retrotransposition and human tumorigenesis[J]. HEREDITAS(Beijing), 2016, 38(2): 93-102.

References

[1] Unwin N. The Croonian Lecture 2000. Nicotinic acetylcholine receptor and the structural basis of fast synaptic transmission. Philos Trans R Soc Lond B Biol Sci , 2000, 355(1404): 1813-1829.
[2] McClintock B. The origin and behavior of mutable loci in maize. Proc Natl Acad Sci USA , 1950, 36(6): 344-355.
[3] Goodier JL, Kazazian HH Jr. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell , 2008, 135(1): 23-35.
[4] Bao WD, Kojima KK, Kohany O. Repbase Update, a database of repetitive elements in eukaryotic genomes. Mob DNA , 2015, 6: 11.
[5] Blikstad V, Benachenhou F, Sperber GO, Blomberg J. Endogenous retroviruses-evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci , 2008, 65(21): 3348-3365.
[6] Belancio VP, Hedges DJ, Deininger P. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res , 2008, 18(3): 343-358.
[7] Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet , 2011, 12: 187-215.
[8] Swergold GD. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol , 1990, 10(12): 6718-6729.
[9] Severynse DM, Hutchison CA 3rd, Edgell MH. Identification of transcriptional regulatory activity within the 5' A-type monomer sequence of the mouse LINE-1 retroposon. Mamm Genome , 1992, 2(1): 41-50.
[10] Feng QH, Moran JV, Kazazian HH Jr, Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell , 1996, 87(5): 905-916.
[11] Martin SL, Li JF, Epperson LE, Lieberman B. Functional reverse transcriptases encoded by A-type mouse LINE-1: defining the minimal domain by deletion analysis. Gene , 1998, 215(1): 69-75.
[12] Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH Jr. High frequency retrotransposition in cultured mammalian cells. Cell , 1996, 87(5): 917-927.
[13] Belgnaoui SM, Gosden RG, Semmes OJ, Haoudi A. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int , 2006, 6: 13.
[14] Babushok DV, Kazazian HH Jr. Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat , 2007, 28(6): 527-539.
[15] Farkash EA, Kao GD, Horman SR, Luning Prak ET. Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Res , 2006, 34(4): 1196-1204.
[16] Gasior SL, Wakeman TP, Xu B, Deininger PL. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Bio , 2006, 357(5): 1383-1393.
[17] Denli AM, Narvaiza I, Kerman BE, Pena M, Benner C, Marchetto MCN, Diedrich JK, Aslanian A, Ma J, Moresco JJ, Moore L, Hunter T, Saghatelian A, Gage FH. Primate-specific ORF0 contributes to retrotransposon-mediated diversity. Cell , 2015, 163(3): 583-593.
[18] Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet , 1997, 13(8): 335-340.
[19] Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature , 2004, 431(7004):96-99.
[20] Kato Y, Kaneda M, Hata K, Kumaki K, Hisano M, Kohara Y, Okano M, Li E, Nozaki M, Sasaki H. Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum Mol Genet , 2007, 16(19): 2272-2280.
[21] Branciforte D, Martin SL. Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition. Mol Cell Biol , 1994, 14(4): 2584-2592.
[22] Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, Kazazian HH Jr. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev , 2009, 23(11): 1303-1312.
[23] Garcia-Perez JL, Marchetto MCN, Muotri AR, Coufal NG, Gage FH, O'Shea KS, Moran

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

The connection between LINE-1 retrotransposition and human tumorigenesis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhong Bian, Dongping Cao, Wenshu Zhuang, Shuwei Zhang, Qiaoquan Liu, Lin Zhang. Revelation of rice molecular design breeding: the blend of tradition and modernity [J]. Hereditas(Beijing), 2023, 45(9): 718-740.
[2]	Xiaoping Lian, Guangfu Huang, Yujiao Zhang, Jing Zhang, Fengyi Hu, Shilai Zhang. The discovery and utilization of favorable genes in Oryza longistaminata [J]. Hereditas(Beijing), 2023, 45(9): 765-780.
[3]	Qingyu Sun, Yang Zhou, Lijuan Du, Mengke Zhang, Jiale Wang, Yuanyuan Ren, Fang Liu. Analysis between macrophage-related genes with prognosis and tumor microenvironment in non-small cell lung cancer [J]. Hereditas(Beijing), 2023, 45(8): 684-699.
[4]	Jun Ma, Anping Fan, Wusheng Wang, Jinchuan Zhang, Xiaojun Jiang, Ruijun Ma, Sheqiang Jia, Fei Liu, Chuchao Lei, Yongzhen Huang. Analysis of genetic diversity and genetic structure of Qinchuan cattle conservation population using whole-genome resequencing [J]. Hereditas(Beijing), 2023, 45(7): 602-616.
[5]	Chenghao Yan, Weiyu Bai, Zhimeng Zhang, Junling Shen, Youjun Wang, Jianwei Sun. The roles and mechanism of STIM1 in tumorigenesis and metastasis [J]. Hereditas(Beijing), 2023, 45(5): 395-408.
[6]	Dantong Xu, Yifei Wang, Jiali Cai, Wentao Gong, Xiangchun Pan, Yuhan Tian, Qingpeng Shen, Jiaqi Li, Xiaolong Yuan. Study on detection of CNVs using human whole genome bisulfite sequencing data [J]. Hereditas(Beijing), 2023, 45(4): 324-340.
[7]	Chunhui Ma, Haixu Hu, Lijuan Zhang, Yi Liu, Tianyi Liu. Establishment and verification of a digital PCR assay for the detection of CK19 expression in quantitative analysis of circulating tumor cell [J]. Hereditas(Beijing), 2023, 45(3): 250-260.
[8]	Chengxian Wang, Yikang S. Rong, Min Cui. The molecular mechanism of Drosophila restricting telomeric transposons [J]. Hereditas(Beijing), 2023, 45(3): 221-228.
[9]	Dong Chang, Xiangxiang Liu, Rui Liu, Jianwei Sun. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression [J]. Hereditas(Beijing), 2023, 45(2): 115-127.
[10]	Zhongsheng Wu, Yu Gao, Yongtao Du, Song Dang, Kangmin He. The protocol of tagging endogenous proteins with fluorescent tags using CRISPR-Cas9 genome editing [J]. Hereditas(Beijing), 2023, 45(2): 165-175.
[11]	Meizhen Liu, Liren Wang, Yongmei Li, Xueyun Ma, Honghui Han, Dali Li. Generation of genetically modified rat models via the CRISPR/Cas9 technology [J]. Hereditas(Beijing), 2023, 45(1): 78-87.
[12]	Xiuli Chen, Haiyan Huang, Qiang Wu. Targeted deletion of 5′HS2 enhancer of β-globin locus control region in K562 cells [J]. Hereditas(Beijing), 2022, 44(9): 783-797.
[13]	Qinggang Hao, Fenggui Sun, Chenghao Yan, Jianwei Sun. Progress on the role and mechanism of MT1-MMP in tumor metastasis [J]. Hereditas(Beijing), 2022, 44(9): 745-755.
[14]	Mengxuan Xu, Ming Zhou. Advances of RNA polymerase IV in controlling DNA methylation and development in plants [J]. Hereditas(Beijing), 2022, 44(7): 567-580.
[15]	Yan Zhao, Chenxin Wang, Tianming Yang, Chunshuang Li, Lihong Zhang, Dongni Du, Ruoxi Wang, Jing Wang, Min Wei, Xueqing Ba. Linking oxidative DNA lesion 8-OxoG to tumor development and progression [J]. Hereditas(Beijing), 2022, 44(6): 466-477.